ClinicalTrials.Veeva

Menu

Validation of a Novel Simplified Head up Tilt Test (HUTT) Protocol Versus the Conventional Protocol

U

University of Campania "Luigi Vanvitelli"

Status

Unknown

Conditions

Syncope
Syncope;Heat Induced

Treatments

Diagnostic Test: Conventional HUTT
Diagnostic Test: Fast HUTT

Study type

Interventional

Funder types

Other

Identifiers

NCT05029323
22062020 (Other Identifier)

Details and patient eligibility

About

The purpose of the study is to compare the positivity rate associated with a novel simplified Tilt-Table (TT) test protocol versus the conventional TT protocol

Full description

All patients with unexplained syncope at initial evaluation with indication to perform a Head up tilt test (HUTT) will be randomized to "conventional" HUTT protocol or "fast" HUTT protocol characterized by a stabilization phase of 5 min in the supine position; a passive phase of 10 min at a tilt angle of 60 degrees; a provocation phase of further 10 min after 300 micrograms NTG sublingual spray. The novel simplified "fast" HUTT protocol has been designed to provide non inferior positivity rates as compared with the conventional protocol in the selected population.

Enrollment

500 estimated patients

Sex

All

Ages

14+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All patients with unexplained syncope at initial evaluation and indication to perform HUTT

Exclusion criteria

  • No informed consent
  • PM/ICD device recipients

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Single Blind

500 participants in 2 patient groups

Conventional HUTT
Active Comparator group
Description:
All patients with unexplained syncope at initial evaluation with indication to perform a Head up tilt test (HUTT) randomized to "conventional" HUTT protocol characterized by a stabilization phase of 5 min in the supine position; a passive phase of 10 min at a tilt angle of 60 degrees; aprovocation phase of further 10 min after 300 micrograms NTG sublingual spray.
Treatment:
Diagnostic Test: Conventional HUTT
Fast HUTT
Experimental group
Description:
All patients with unexplained syncope at initial evaluation with indication to perform a Head up tilt test (HUTT) randomized to "fast" HUTT protocol characterized by a stabilization phase of 5 min in the supine position; a passive phase of 10 min at a tilt angle of 60 degrees; a provocation phase of further 10 min after 300 micrograms NTG sublingual spray.
Treatment:
Diagnostic Test: Fast HUTT

Trial contacts and locations

1

Loading...

Central trial contact

Vincenzo Russo, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems